Gene Logic Inc. (NASDAQ:GLGC) announced that Takeda Pharmaceutical Company Limited has extended its subscription to Gene Logic's BioExpress(R) System. The agreement with Takeda permits use of the system as a primary tool for drug discovery and development. Takeda extended their access to new BioExpress System data through 2006 and also obtained a perpetual license to the data existing as of the commencement date of the latest agreement. Financial terms of the agreement were not disclosed. The BioExpress System consists of comprehensive genomic and clinical information derived from a broad range of normal and diseased human tissues, treated and untreated tissues from model animal systems and human and animal cell lines. The BioExpress System and its related bioinformatics interface are used by pharmaceutical companies for specific research and development activities including data mining, analysis, indexing and visualization. "Takeda is the largest pharmaceutical company in Japan, and has been a very important client of ours for the past three years," said Dennis Rossi, senior vice president and general manager, genomics for Gene Logic. "We're pleased to continue providing solutions to assist Takeda in their drug discovery and development efforts. Japan is a significant market for our company and a vital part of the global life sciences industry. We established Gene Logic K.K., a wholly owned subsidiary in Tokyo staffed with bilingual customer service and technical support people, to better serve that market." Gene Logic Overview Gene Logic aspires to be the most valued drug development solutions provider for the pharmaceutical industry. Gene Logic applies its broad and unique mix of technologies, talent and methodologies to work on behalf of its partners to enable pharmaceutical and biotechnology companies to make more informed, more reliable and more predictive decisions at each point in the highly complex and costly drug development process. For more information, visit www.genelogic.com or call toll-free - 1/800/GENELOGIC.
Gene Logic Inc. (MM) (NASDAQ:GLGC)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Gene Logic Inc.  (MM) Charts.
Gene Logic Inc. (MM) (NASDAQ:GLGC)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Gene Logic Inc.  (MM) Charts.